anti-FGb antibody product blogThe FGb n/a (Catalog #MBS2052624) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Biotin-Linked Monoclonal Antibody to Fibrinogen Beta (FGb) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Fibrinogen Beta (FGb) can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC).
Western Blot: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml. Researchers should empirically determine the suitability of the FGb n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Biotin-Linked Monoclonal Antibody to Fibrinogen Beta (FGb) with the following immunoassay(s):
Knockout Validation (Knockout Validation: Lane 1: Wild-type Hela cell lysate;;Lane 2: FGb knockout Hela cell lysate;;Predicted MW: 56kDa ;Observed MW: 56kDa;Primary Ab: 2ug/ml Rabbit Anti-Human FGb Antibody;Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody;(#MBS2086047))
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing FGb are readily searchable from our website. Different antibodies against the same target such as FGb may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.